It would be news if IBM didn't get the most U.S. patents in 2006.
So it's no surprise that the company did just that for the 14th consecutive year. But it's still worth noting the number of patents Big Blue was awarded--3,651--especially in light of various efforts to reform what some say is a flawed system to balance intellectual property and innovation. Not to mention IBM's continued willingness to launch patent infringement lawsuits and the fact that smaller companies eagerly trumpet the award of even a single patent.
IBM plans to tout its patent tally Wednesday. Second place went to Samsung Electronics, with 2,453 patents, followed by Canon with 2,378, Matsushita Electronics with 2,273, Hewlett-Packard with 2,113, Intel with 1,962, and Sony with 1,810.
Patents can be a lucrative source of revenue for technology companies that license their intellectual property to others. And patents can give strategic leverage to competitive negotiations, as in recent deals that Novell and Sun Microsystems signed with rival Microsoft.
But patents can be a pain, too. Amazon.com and IBM are locked in a legal battle about e-commerce patents. A patent infringement suit costs $3 million to defend, intellectual property lawyers estimate.
The latest modest-scale patent reform plan IBM is involved in is an online meeting called the Inventors' Forum where smaller companies or individual inventors, such as Super Soaker patent holder Lonnie Johnson, can have their say. The company plans to announce the forum Wednesday.
Web giant is spending $120 million to beef up its Mountain View, Calif., headquarters, according to filings with the city reviewed by the San Jose Mercury News.
The Samsung Galaxy Mini 2 S6500 could make its debut at the Mobile World Congress in Barcelona later this month, according to a leaked promotional image.
MIT creates a simulation to celebrate the 50th anniversary of Spacewar. A relic of the early days of minicomputers, it was one of the first computer video games and set the stage for many others, including Asteroids.
Join the conversation